Anti-IL2 receptor monoclonal antibody (33B3.1) in prophylaxis of early kidney rejection in humans: a randomized trial versus rabbit antithymocyte globulin. [electronic resource]
Producer: 19890601Description: 1769-71 p. digitalISSN:- 0041-1345
- Adolescent
- Adult
- Animals
- Antibodies, Monoclonal -- adverse effects
- Antilymphocyte Serum -- adverse effects
- Clinical Trials as Topic
- Communicable Diseases -- etiology
- Female
- Graft Rejection
- Humans
- Interleukin-2 -- immunology
- Kidney Transplantation
- Male
- Middle Aged
- Rabbits -- immunology
- Random Allocation
- Receptors, Interleukin-2 -- immunology
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.